These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26568600)

  • 1. Outcome Measures in Polymyalgia Rheumatica. A Systematic Review.
    Duarte C; Ferreira RJ; Mackie SL; Kirwan JR; Pereira da Silva JA;
    J Rheumatol; 2015 Dec; 42(12):2503-11. PubMed ID: 26568600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Provisional Core Domain Set for Polymyalgia Rheumatica: Report from the OMERACT 12 Polymyalgia Rheumatica Working Group.
    Helliwell T; Brouwer E; Pease CT; Hughes R; Hill CL; Neill LM; Halls S; Simon LS; Mallen CD; Boers M; Kirwan JR; Mackie SL
    J Rheumatol; 2016 Jan; 43(1):182-6. PubMed ID: 26568595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyalgia Rheumatica (PMR) Special Interest Group at OMERACT 11: outcomes of importance for patients with PMR.
    Mackie SL; Arat S; da Silva J; Duarte C; Halliday S; Hughes R; Morris M; Pease CT; Sherman JW; Simon LS; Walsh M; Westhovens R; Zakout S; Kirwan JR
    J Rheumatol; 2014 Apr; 41(4):819-23. PubMed ID: 24488422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review.
    Twohig H; Owen C; Muller S; Mallen CD; Mitchell C; Hider S; Hill C; Shea B; Mackie SL
    J Rheumatol; 2021 Jun; 48(6):883-893. PubMed ID: 32739892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The OMERACT Core Domain Set for Outcome Measures for Clinical Trials in Polymyalgia Rheumatica.
    Mackie SL; Twohig H; Neill LM; Harrison E; Shea B; Black RJ; Kermani TA; Merkel PA; Mallen CD; Buttgereit F; Mukhtyar C; Simon LS; Hill CL;
    J Rheumatol; 2017 Oct; 44(10):1515-1521. PubMed ID: 28765246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a Core Outcome Measurement Set for Polymyalgia Rheumatica: Report from the OMERACT 2018 Special Interest Group.
    Owen CE; Yates M; Twohig H; Muller S; Neill LM; Harrison E; Shea B; Simon LS; Hill CL; Mackie SL
    J Rheumatol; 2019 Oct; 46(10):1360-1364. PubMed ID: 30709960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of polymyalgia rheumatica: a systematic review.
    Hernández-Rodríguez J; Cid MC; López-Soto A; Espigol-Frigolé G; Bosch X
    Arch Intern Med; 2009 Nov; 169(20):1839-50. PubMed ID: 19901135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study.
    McCarthy EM; MacMullan PA; Al-Mudhaffer S; Madigan A; Donnelly S; McCarthy CJ; Molloy ES; Kenny D; McCarthy GM
    J Rheumatol; 2014 May; 41(5):931-7. PubMed ID: 24692520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study.
    Yates M; Owen CE; Muller S; Graham K; Neill L; Twohig H; Boers M; Pujades Rodriguez M; Goodman SM; Cheah J; Dejaco C; Mukhtyar C; Nielsen BD; Robson J; Simon LS; Shea B; Mackie SL; Hill CL;
    J Rheumatol; 2020 Sep; 47(9):1379-1384. PubMed ID: 32007937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus.
    Dejaco C; Duftner C; Cimmino MA; Dasgupta B; Salvarani C; Crowson CS; Maradit-Kremers H; Hutchings A; Matteson EL; Schirmer M;
    Ann Rheum Dis; 2011 Mar; 70(3):447-53. PubMed ID: 21097803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).
    Leeb BF; Bird HA; Nesher G; Andel I; Hueber W; Logar D; Montecucco CM; Rovensky J; Sautner J; Sonnenblick M
    Ann Rheum Dis; 2003 Dec; 62(12):1189-94. PubMed ID: 14644857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-reported outcomes in trials of patients with polymyalgia rheumatica: a systematic literature review.
    Huang A; Castrejon I
    Rheumatol Int; 2016 Jul; 36(7):897-904. PubMed ID: 26769433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Corticosteroid sparing agents for polymyalgia rheumatica and arteritis temporalis (Horton's disease)].
    Volken JJ; Karrer W
    Praxis (Bern 1994); 2004 Jun; 93(25-26):1103-6. PubMed ID: 15317301
    [No Abstract]   [Full Text] [Related]  

  • 14. Perspectives and unmet needs in polymyalgia rheumatica. Providing the fundamental framework for the development of new treatment regimes in polymyalgia rheumatica.
    Nielsen BD; Dasgupta B
    Reumatismo; 2018 Mar; 70(1):1-9. PubMed ID: 29589397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current evidence for therapeutic interventions and prognostic factors in polymyalgia rheumatica: a systematic literature review informing the 2015 European League Against Rheumatism/American College of Rheumatology recommendations for the management of polymyalgia rheumatica.
    Dejaco C; Singh YP; Perel P; Hutchings A; Camellino D; Mackie S; Matteson EL; Dasgupta B
    Ann Rheum Dis; 2015 Oct; 74(10):1808-17. PubMed ID: 26359489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyalgia rheumatica: clinical update.
    Ameer F; McNeil J
    Aust Fam Physician; 2014 Jun; 43(6):373-6. PubMed ID: 24897986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyalgia rheumatica: clinical picture and principles of treatment.
    Zimmermann-Górska I
    Pol Arch Med Wewn; 2008 Jun; 118(6):377-80. PubMed ID: 18619195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-reported outcomes in polymyalgia rheumatica.
    Matteson EL; Maradit-Kremers H; Cimmino MA; Schmidt WA; Schirmer M; Salvarani C; Bachta A; Dejaco C; Duftner C; Slott Jensen H; Poór G; Kaposi NP; Mandl P; Balint PV; Schmidt Z; Iagnocco A; Cantini F; Nannini C; Macchioni P; Pipitone N; Del Amo M; Espígol-Frigolé G; Cid MC; Martínez-Taboada VM; Nordborg E; Direskeneli H; Aydin SZ; Ahmed K; Hazelman B; Pease C; Wakefield RJ; Luqmani R; Abril A; Marcus R; Gonter NJ; Maz M; Crowson CS; Dasgupta B
    J Rheumatol; 2012 Apr; 39(4):795-803. PubMed ID: 22422492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement Properties of the Polymyalgia Rheumatica Activity Score: A Systematic Literature Review.
    Bolhuis TE; Nizet LEA; Owen C; den Broeder AA; van den Ende CHM; van der Maas A
    J Rheumatol; 2022 Jun; 49(6):627-634. PubMed ID: 35232811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.
    Hutchings A; Hollywood J; Lamping DL; Pease CT; Chakravarty K; Silverman B; Choy EH; Scott DG; Hazleman BL; Bourke B; Gendi N; Dasgupta B
    Arthritis Rheum; 2007 Jun; 57(5):803-9. PubMed ID: 17530680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.